JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3001
Kyndryl
KD
$2.5B
| $3.45M | ﹤0.01% |
310,196
-173,576
| -36% | -$1.75M |
2021 Q4
4 quarters
|
|
3002
Stock Yards Bancorp
SYBT
$2.39B
| $3.43M | ﹤0.01% |
52,777
+3,695
| +8% | +$264K |
2013 Q2
38 quarters
|
|
3003
Seres Therapeutics
MCRB
$29.1M
| $3.43M | ﹤0.01% |
30,627
-4,892
| -14% | -$656K |
2015 Q2
30 quarters
|
|
3004
State Street SPDR S&P Health Care Equipment ETF
XHE
$181M
| $3.42M | ﹤0.01% |
38,062
+1,172
| +3% | +$103K |
2017 Q2
22 quarters
|
|
3005
Simplify Hedged Equity ETF
HEQT
$325M
| $3.42M | ﹤0.01% |
151,587
+141,587
| +1,416% | +$3.3M |
2021 Q4
4 quarters
|
|
3006
Global X MLP ETF
MLPA
$2.32B
| $3.42M | ﹤0.01% |
82,801
+80,510
| +3,514% | +$3.37M |
2021 Q1
7 quarters
|
|
3007
TG Therapeutics
TGTX
$7.99B
| $3.4M | ﹤0.01% |
287,816
-942
| -0.3% | -$6.84K |
2016 Q4
24 quarters
|
|
|
HJEN
3008
DELISTED
Direxion Hydrogen ETF
HJEN
| $3.4M | ﹤0.01% |
250,000
| – | – |
2021 Q1
7 quarters
|
|
3009
Endava
DAVA
$99.3M
| $3.39M | ﹤0.01% |
44,336
+36,976
| +502% | +$2.75M |
2020 Q1
11 quarters
|
|
3010
CALL
BioCryst Pharmaceuticals
BCRX
$2.03B
| $3.39M | ﹤0.01% |
+295,000
| New | +$3.68M |
2022 Q4
0 quarters
|
|
|
SEI
3011
Solaris Energy Infrastructure
SEI
$5.25B
| $3.38M | ﹤0.01% |
340,509
-16,228
| -5% | -$178K |
2017 Q3
21 quarters
|
|
3012
The GEO Group
GEO
$3.94B
| $3.38M | ﹤0.01% |
308,357
-1,891,923
| -86% | -$18.4M |
2014 Q3
33 quarters
|
|
3013
Fidelity MSCI Industrials Index ETF
FIDU
$2.23B
| $3.37M | ﹤0.01% |
+66,493
| New | +$3.3M |
2022 Q4
0 quarters
|
|
3014
PUT
Warner Bros
WBD
$77.6B
| $3.37M | ﹤0.01% |
355,700
| – | – |
2022 Q2
2 quarters
|
|
|
TRTX
3015
TPG RE Finance Trust
TRTX
$464M
| $3.37M | ﹤0.01% |
496,492
-110,005
| -18% | -$811K |
2017 Q4
20 quarters
|
|
|
SNBR
3016
DELISTED
Sleep Number
SNBR
| $3.36M | ﹤0.01% |
129,460
+35,756
| +38% | +$1.09M |
2014 Q3
33 quarters
|
|
3017
HNI Corp
HNI
$3.37B
| $3.36M | ﹤0.01% |
118,123
-63,667
| -35% | -$1.81M |
2013 Q2
38 quarters
|
|
|
XRN
3018
Chiron Real Estate Inc
XRN
$454M
| $3.36M | ﹤0.01% |
70,808
-37,129
| -34% | -$1.68M |
2017 Q4
20 quarters
|
|
3019
Transocean
RIG
$6.03B
| $3.34M | ﹤0.01% |
732,523
-37,310
| -5% | -$144K |
2013 Q2
38 quarters
|
|
3020
CALL
Illumina
ILMN
$41.3B
| $3.34M | ﹤0.01% |
16,962
+7,607
| +81% | +$1.58M |
2022 Q2
2 quarters
|
|
3021
MP Materials
MP
$8.64B
| $3.33M | ﹤0.01% |
137,190
-34,075
| -20% | -$1.03M |
2021 Q2
6 quarters
|
|
3022
Amalgamated Financial
AMAL
$1.42B
| $3.33M | ﹤0.01% |
144,447
-104,513
| -42% | -$2.53M |
2018 Q3
17 quarters
|
|
3023
iShares US Equity Factor ETF
LRGF
$3.76B
| $3.32M | ﹤0.01% |
+85,209
| New | +$3.33M |
2022 Q4
0 quarters
|
|
3024
Orthofix Medical
OFIX
$383M
| $3.32M | ﹤0.01% |
161,833
-4,853
| -3% | -$85.6K |
2015 Q2
30 quarters
|
|
3025
CALL
Lam Research
LRCX
$418B
| $3.32M | ﹤0.01% |
79,000
+10,000
| +14% | +$418K |
2021 Q1
7 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.